Neos Therapeutics, Inc
NEOS
NEOS was delisted on the 19th of March, 2021.
58 hedge funds and large institutions have $29.4M invested in Neos Therapeutics, Inc in 2019 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 15 closing their positions.
50% more call options, than puts
Call options by funds: $3K | Put options by funds: $2K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 17
8% less funds holding
Funds holding: 63 → 58 (-5)
20% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 15
59% less capital invested
Capital invested by funds: $71.2M → $29.4M (-$41.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$2.78M |
| 2 |
Goldman Sachs
New York
|
+$2.22M |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$845K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$392K |
| 5 |
AIM
Alambic Investment Management
Belvedere,
California
|
+$381K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$5.29M |
| 2 |
BC
Broadfin Capital
New York
|
-$4.21M |
| 3 |
BlackRock
New York
|
-$3.94M |
| 4 |
DM
Deerfield Management
New York
|
-$2.72M |
| 5 |
State Street
Boston,
Massachusetts
|
-$1.14M |
NEOS Hedge Fund Activity: Q2 2019 in Review
58 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Neos Therapeutics, Inc (NEOS) for Q2 2019, worth a combined $29.4M — down 59% from $71.2M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of NEOS and 12 opened new positions — a net loss of 3 holders — while 17 trimmed existing stakes and 17 added.
The largest buyer was Sphera Funds Management, adding an estimated $2.78M. The largest seller was Franklin Resources, exiting entirely with an estimated $5.29M sold.
- 58 institutional investors held Neos Therapeutics, Inc (NEOS) as of Q2 2019, down from 63 in Q1 2019.
- Funds reported $29.4M of Neos Therapeutics, Inc stock for Q2 2019, down 59% quarter-over-quarter.
- 12 funds opened new Neos Therapeutics, Inc positions in Q2 2019 and 15 closed out, a net change of -3 holders.
- The largest Neos Therapeutics, Inc buyer in Q2 2019 was Sphera Funds Management, an estimated $2.78M added.
- The largest Neos Therapeutics, Inc seller in Q2 2019 was Franklin Resources, an estimated $5.29M sold.
Based on aggregated 13F filings for Q2 2019.